During the past decade, Mir Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mir Neurology" are "Agitation in Participants With Dementia of the Alzheimer's Type" (1 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials) and "Symptomatic Neurogenic Orthostatic Hypotension" (1 trials). Many other conditions were trialed in "Mir Neurology" in a lesser frequency.

Most popular intervention types in "Mir Neurology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "AVP-786" (1 trials), "AVP-786-18" (1 trials), "AVP-786-28" (1 trials), "AVP-786-42.63" (1 trials) and "Droxidopa capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mir Neurology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mir Neurology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mir Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mir Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".